Comments

Pasithea Therapeutics (KTTAW) Stock Price, Quote, News & History

KTTAWNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$0.0309

0.00093.00%

At close: Dec 15, 4:00 PM EST

$0.0370

0.006119.74%

After Hours: Dec 12, 9:18 AM EST

Overview

News Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$0.03

Volume / Avg.

15.43K / 71.78K

Day Range

$0.03 - $0.03

52 Wk Range

0.01 - 0.12

Market Cap

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Pasithea Therapeutics Corp News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Key Statistics

Open

$0.03

Volume / Avg.

15.43K / 71.78K

Day Range

$0.03 - $0.03

52 Wk Range

0.01 - 0.12

Market Cap

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry